Published in J Biol Chem on January 02, 1998
The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol (1999) 2.00
Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol (2004) 1.91
Chemistry and structural biology of androgen receptor. Chem Rev (2005) 1.72
The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol (1999) 1.70
AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. Mol Cell Biol (2003) 1.68
Nuclear actin and actin-binding proteins in the regulation of transcription and gene expression. FEBS J (2009) 1.49
Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone. J Biol Chem (2007) 1.47
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal (2008) 1.47
Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol Cell Biol (2006) 1.28
Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem J (2005) 1.27
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs. Mol Cell Biol (2003) 1.24
Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin (2014) 1.15
Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation. Endocr Rev (2012) 1.11
Epidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor. Mol Cell Biol (2008) 1.07
The role of androgen receptor mutations in prostate cancer progression. Curr Genomics (2009) 1.07
Unbinding of retinoic acid from the retinoic acid receptor by random expulsion molecular dynamics. Biophys J (2006) 1.05
Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase. Mol Endocrinol (2008) 1.03
An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy. J Biol Chem (2010) 1.03
Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators. J Biol Chem (2009) 1.01
The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor. Mol Cell Biol (2012) 0.98
Phosphorylation of androgen receptor isoforms. Biochem J (2004) 0.98
Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling. J Biol Chem (2010) 0.97
Coordinated action of hypoxia-inducible factor-1α and β-catenin in androgen receptor signaling. J Biol Chem (2012) 0.95
Ligand binding to the androgen receptor induces conformational changes that regulate phosphatase interactions. Mol Cell Biol (2007) 0.95
Profiling human androgen receptor mutations reveals treatment effects in a mouse model of prostate cancer. Mol Cancer Res (2008) 0.94
Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile. Proc Natl Acad Sci U S A (2007) 0.92
Structural features discriminate androgen receptor N/C terminal and coactivator interactions. Mol Cell Endocrinol (2011) 0.90
Evolutionary history and functional characterization of androgen receptor genes in jawed vertebrates. Endocrinology (2009) 0.89
Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells. Int J Biochem Cell Biol (2012) 0.89
Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions. J Clin Invest (1999) 0.87
Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine. PLoS One (2009) 0.87
A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression. EMBO J (2006) 0.86
Structural and functional characterization of the interdomain interaction in the mineralocorticoid receptor. Mol Endocrinol (2009) 0.85
Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation. J Biol Chem (2012) 0.85
Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic. Mol Endocrinol (2009) 0.84
Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcription. BMC Biochem (2013) 0.83
The chicken ovalbumin upstream promoter-transcription factor II negatively regulates the transactivation of androgen receptor in prostate cancer cells. PLoS One (2012) 0.83
Identification of anabolic selective androgen receptor modulators with reduced activities in reproductive tissues and sebaceous glands. J Biol Chem (2009) 0.82
Analysis of interdomain interactions of the androgen receptor. Methods Mol Biol (2011) 0.82
Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer. PLoS One (2012) 0.82
Discovery of the selective androgen receptor modulator MK-0773 using a rational development strategy based on differential transcriptional requirements for androgenic anabolism versus reproductive physiology. J Biol Chem (2010) 0.82
Characterization of niphatenones that inhibit androgen receptor N-terminal domain. PLoS One (2014) 0.82
The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy. Curr Drug Targets (2013) 0.80
Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy. CNS Neurol Disord Drug Targets (2013) 0.80
Structure-based virtual screening and identification of a novel androgen receptor antagonist. J Biol Chem (2012) 0.80
Gain in transcriptional activity by primate-specific coevolution of melanoma antigen-A11 and its interaction site in androgen receptor. J Biol Chem (2011) 0.80
Muscle-bound? A tissue-selective nonsteroidal androgen receptor modulator. Endocrinology (2007) 0.79
Dysregulation of neonatal hippocampal cell genesis in the androgen insensitive Tfm rat. Horm Behav (2013) 0.79
Sex- and age-dependent effects of androgens on glutamate-induced cell death and intracellular calcium regulation in the developing hippocampus. Neuroscience (2014) 0.76
Research resource: EPSLiM: ensemble predictor for short linear motifs in nuclear hormone receptors. Mol Endocrinol (2014) 0.76
Engineered repressors are potent inhibitors of androgen receptor activity. Oncotarget (2014) 0.76
Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy. Cancers (Basel) (2017) 0.75
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature (1991) 9.89
Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature (1995) 6.33
Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev (1995) 4.22
Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res (2001) 4.12
Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science (1988) 3.40
A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res (2001) 3.37
Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem (1991) 2.79
FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem (2000) 2.58
The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol (1988) 2.36
A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J Biol Chem (1994) 2.35
Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci U S A (1989) 2.28
Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. Blood (1977) 2.05
Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. J Biol Chem (1999) 2.00
Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol (1997) 1.90
The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: a degenerate conserved cleavage motif within core proteins. Virology (1991) 1.86
Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol (1995) 1.83
Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc Natl Acad Sci U S A (1988) 1.76
Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet (1989) 1.74
Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem (1992) 1.73
Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem (1995) 1.54
Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation. J Mol Biol (2000) 1.53
Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem (2001) 1.51
The androgen receptor: an overview. Recent Prog Horm Res (1994) 1.48
Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J Biol Chem (1995) 1.45
Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol Endocrinol (1995) 1.41
Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol (1990) 1.40
A frameshift mutation destabilizes androgen receptor messenger RNA in the Tfm mouse. Mol Endocrinol (1991) 1.39
Hormone-dependent transactivation by the human androgen receptor is regulated by a dnaJ protein. J Biol Chem (1995) 1.39
A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J Biol Chem (1990) 1.37
Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol Endocrinol (1999) 1.32
Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications. J Mol Med (Berl) (1997) 1.31
Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains. J Biol Chem (1993) 1.27
Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology (1990) 1.23
Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem (1997) 1.23
Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivo. Mol Endocrinol (1992) 1.20
Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. J Biol Chem (1976) 1.20
Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily. J Clin Endocrinol Metab (1999) 1.19
Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol (1996) 1.17
Ligand-independent oligomerization of natriuretic peptide receptors. Identification of heteromeric receptors and a dominant negative mutant. J Biol Chem (1992) 1.17
Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 coactivator recruitment by activation function 2. J Biol Chem (2001) 1.17
EMS Agenda for the Future: where we are...where we want to be. Prehosp Emerg Care (1998) 1.16
Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression. Mol Endocrinol (2004) 1.16
Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology (1999) 1.16
Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system. Neurobiol Dis (1997) 1.13
Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci U S A (1989) 1.13
The rat androgen receptor: primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein. Mol Endocrinol (1988) 1.13
Response elements of the androgen-regulated C3 gene. J Biol Chem (1992) 1.10
The putative androgen receptor-A form results from in vitro proteolysis. J Mol Endocrinol (2001) 1.08
EMS agenda for the future: where we are ... where we want to be. EMS Agenda for the Future Steering Committee. Ann Emerg Med (1998) 1.07
Zinc potentiation of androgen receptor binding to nuclei in vitro. Biochemistry (1984) 1.06
An androgen-inducible expression system for Saccharomyces cerevisiae. Gene (1991) 1.05
Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nat Genet (1995) 1.05
Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25. J Virol (1990) 1.05
Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. Endocrinology (2001) 1.02
Construction of recombinant vaccinia virus strains using single-stranded DNA insertion vectors. Gene (1986) 1.00
Androgen suppression of GnRH-stimulated rat LHbeta gene transcription occurs through Sp1 sites in the distal GnRH-responsive promoter region. Mol Endocrinol (2001) 1.00
Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J Clin Endocrinol Metab (1998) 1.00
Comparison of continuous and intermittent anorectic therapy in obesity. Br Med J (1968) 1.00
Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc Natl Acad Sci U S A (1990) 0.99
Identification of androstenedione in a river containing paper mill effluent. Environ Toxicol Chem (2001) 0.99
Regional cerebral blood flow by 133xenon inhalation. Stroke (1975) 0.98
Antiandrogens as environmental endocrine disruptors. Reprod Fertil Dev (1998) 0.97
133Xenon inhalation method. Analysis of reproducibility: some of its physiological implications. Stroke (1977) 0.96
Expression of recombinant androgen receptor in cultured mammalian cells. Mol Endocrinol (1990) 0.96
Isolation and analysis of vaccinia virus previrions. Virus Genes (1993) 0.96
Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue. J Urol (1993) 0.95
Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. Clin Cancer Res (1996) 0.94
Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity. Mol Endocrinol (1990) 0.94
Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding. J Clin Endocrinol Metab (2001) 0.94
Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J Clin Endocrinol Metab (1992) 0.94
Chromatin of the developing chick oviduct: changes in the acidic proteins. Biochim Biophys Acta (1973) 0.93
Trinucleotide repeats in the human androgen receptor: a molecular basis for disease. J Mol Endocrinol (1998) 0.93
Androgen and glucocorticoid receptors interact with insulin degrading enzyme. J Biol Chem (1994) 0.93
Molecular cloning of rat prostate transglutaminase complementary DNA. The major androgen-regulated protein DP1 of rat dorsal prostate and coagulating gland. J Biol Chem (1992) 0.91
Molecular cloning of complementary deoxyribonucleic acid for an androgen-regulated epididymal protein: sequence homology with metalloproteins. Mol Endocrinol (1988) 0.91
Hemispheric specialization in normal man studied by bilateral measurements of the regional cerebral blood flow. A study with the 133-Xe inhalation technique. Brain (1975) 0.91
Agonist and antagonist activities of hydroxyflutamide and Casodex relate to androgen receptor stabilization. Urology (1996) 0.90
Immunocytochemical localization of androgen receptors in the male songbird and quail brain. J Comp Neurol (1992) 0.90
Evolution of the primate androgen receptor: a structural basis for disease. J Mol Evol (1998) 0.89
The androgen receptor gene is located on a highly conserved region of the X chromosomes of marsupial and monotreme as well as eutherian mammals. J Hered (1991) 0.89
Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis. Cancer Res (1996) 0.89
Effect of dietary compliance on metabolic control in insulin-dependent diabetics. Hum Nutr Appl Nutr (1983) 0.88
Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique. Mol Endocrinol (1992) 0.88
Regional and splenic lymphocyte proliferative responses of mice exposed to normal or irradiated Schistosoma mansoni cercariae. Am J Trop Med Hyg (1982) 0.87
Production and purification of histidine-tagged dihydrotestosterone-bound full-length human androgen receptor. Methods Mol Biol (2001) 0.87
Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma. Cancer Res (1990) 0.86
Validation of jugular venous flow as an index of total cerebral blood flow. Stroke (1972) 0.86
Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. J Biol Chem (1993) 0.85
Cortisol alters gene expression during involution of the rat ventral prostate. Mol Endocrinol (1989) 0.85
Expression of streptococcal M protein in mammalian cells. Proc Natl Acad Sci U S A (1988) 0.85